ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 284751 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 284751; 2) Community: the network communities that were significantly associated with the response to NSC 284751; 3) Molecule: the relationships between components within communities and NSC 284751; 4) MDR: the compounds that were significantly associated with the NSC 284751.

NSC Compound Enrichment Correlation
NSC 645566 Null 0.0422011701988039 0.048067627
NSC 667707 Null 0.0422011701988039 0.19768121
NSC 670664 Null 0.0422011701988039 0.20967859
NSC 675000 Null 0.0422011701988039 0.33202021
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0422011701988039 0.55285755
NSC 681239 Bortezomib 0.0422011701988039 -0.029347295
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.0422011701988039 0.30541399
NSC 683558 Camptothecin Derivative 0.0422011701988039 0.31017048
NSC 686583 Null 0.0422011701988039 0.25671018
NSC 690270 ANTINEOPLASTIC-690270 0.0422011701988039 0.30652543
Total:146  Current:118    [First] [Prev] [Next] [Last]